Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

  • Comisión Europea
  • Publicaciones
  • Una industria farmacéutica europea más fuerte en beneficio del paciente. Un llamamiento para la acción. Comunicación de la Comisión al Consejo, al Parlamento Europeo [...].COM(2003) 383 final


It has long been recognised that the European-based pharmaceutical industry plays a critical role in both the industrial and health sectors. Concerned to tackle a growing weakness in the industry, the Commission set up a High Level Group on Innovation and the Provision of Medicines - the so-called \"G10 Medicines Group\". The (G10 Medicines Group report) was published in May 2002, and the present Communication is the Commision s response to the 14 recommendations of that report.

The Communication divides the recommendations into the following five broad themes:
- Benefits to Patients
- Developing a competitive European-based industry
- Strengthening the EU Science Base
- Medicines in an enlarged European Union
- Member States learning from each other
In each area it sets out how the Commission would like the recommendations to be taken forward and, in areas of national competence, a proposed direction it believes Member States could take and what the Commission can do to facilitate the process.

Descargar application/pdf (368382)

Número de registro: 4995 / Última actualización el: 2003-07-09
Categoría: comDocument